Optomed Oyj Class A · OMXHEX:OPTOMED
Optomed Oyj Class A — Q2 2026 Earnings Presentation
16 slides from Optomed Oyj Class A's earnings presentation, Aug 14, 2026
Slide 1: Optomed Q2 2026
Optomed Q2 2026 14th August 2026 Juho Himberg, CEO Sakari Knuutti, CFO
Slide 2: Highlights Q2
Highlights Q2 1. 2. 3. Revenue mix continued Revenue declined, but Q2 operating cash flow to shift toward recurring, profitability improved improved, and balance software and AI-driven materially sheet remained strong revenue Approximately USD 2.1 million US order received and will be delivered in H
Slide 3: Q2-2026 Key Figures
Q2-2026 Key Figures PROFITABILITY IMPROVED MATERIALLY Q2/2026 Q2/2025 Change Revenue 3,515 3,845 -8.6% Gross profit 2,505 2,496 0.3% Gross margin 71.3% 64.9% +6.3pp EBITDA -457 -921 50.4% EBITDA margin -13.0% -23.9% +11.0pp Net profit / loss -935 -1,644 43.2% Earnings per share -0.05 -0.08 46.1% Cas
Slide 4: H1-2026 Key Figures
H1-2026 Key Figures H1/2026 H1/2025 Change Revenue 6,866 7,866 -12.7% Gross profit 4,807 5,190 -7.4% Gross margin 70.0% 66.0% +4.0pp EBITDA -1,158 -1,658 30.2% EBITDA margin -16.9% -21.1% +4.2pp Net profit / loss -2,035 -3,225 36.9% Earnings per share -0.10 -0.16 40.2% Cash flow from operating activ
Slide 5: Segment highlights
Segment highlights OPT@MED
Slide 6: Devices Segment Q2-2026
Devices Segment Q2-2026 CONTINUED TRANSFORMATION FROM CAMERA SALES TOWARDS RECURRING AI-ENABLED SCREENING SOLUTIONS Q2/2026 Q2/2025 Change US and AI revenue increased, while 1. revenue outside the US was below the comparison period. Revenue 1,150 1,409 -18.4% Gross margin improved supported Gross pr
Slide 7: Devices Gross Margin Development
Devices Gross Margin Development SHIFT TOWARD RECURRING REVENUE SUPPORTING STRUCTURALLY HIGHER MARGINS 75% 72% +18pp vs. Q3-25 70% 65% 63% 60% 55% 55% 54% 50% 45% 40% Q3-25 Q4-25 Q1-26 Q2-26
Slide 8: Software Segment Q2-2026
Software Segment Q2-2026 INCREASING MARGINS Q2/2026 Q2/2025 Change Revenue declined modestly, 1. reflecting slight decreases in consulting and healthcare services. Revenue 2,365 2,435 -2.9% EBITDA improved to EUR 0.5 Gross profit 1,679 1,690 -0.7% 2. million, corresponding to a 19.5% EBITDA margin.
Slide 9: Cash Flow Q2-2026
Cash Flow Q2-2026 CASH POSITION AT EUR 6.7 MILLION Q2 2026 Q2 2025 Loss for the financial year -935 -1,644 • Significantly improved cash flow Cash flows before change -335 -770 in net working capital vs last year. Change in net working capital 90 -885 • Net decrease in cash and cash Cash flows befor
Slide 10: Outlook 2026
Outlook 2026 OPTOMED EXPECTS ITS FULL YEAR 2026 REVENUE TO GROW COMPARED TO 2025 Key items supporting Areas of uncertainty and pressure our growth: on growth: • Larger Aurora AEYE recurring revenue • Transition to service and recurring revenue base compared with the prior year models may affect shor
Slide 11: Q2-2026 in summary
Q2-2026 in summary • Revenue mix continued to shift toward recurring, software and AI-related revenue • Profitability improved materially • Q2 operating cash flow improved significantly, and cash position remained solid • Aurora AEYE deployments and recurring AI-related revenue continued to progress
Slide 12: Appendix
Appendix OPT@MED
Slide 13: Devices Segment H1-2026
Devices Segment H1-2026 H1/2026 H1/2025 Change Revenue 2,216 2,935 -24.5% Gross profit 1,494 1,704 -12.3% Gross margin 67.4 % 58.0 % +9.4pp EBITDA -398 -594 33.1% EBITDA margin -17.9 % -20.2 % +2.3pp
Slide 14: Software Segment H1-2026
Software Segment H1-2026 H1/2026 H1/2025 Change Revenue 4,650 4,931 -5.7% Gross profit 3,313 3,486 -4.9% Gross margin 71.3 % 70.7 % +0.6pp EBITDA 939 913 2.9% EBITDA margin 20.2 % 18.5 % +1.7pp
Slide 15: Cash Flow H1-2026
Cash Flow H1-2026 H1 2026 H1 2025 Loss for the financial year -2,035 -3,225 Cash flows before change in net working capital -876 -1,489 Change in net working capital -802 184 Cash flows before finance items -1,678 -1,305 Cash flows from finance items -17 -3 Net cash from operating activities -1,695
Slide 16: Balance Sheet
Balance Sheet 30 June 2026 30 June 2025 ASSETS • Equity ratio of 76.1 (74.9) Goodwill 4,256 4,256 percent Development costs 8,701 8,687 Other intangible assets 927 1,244 • Total borrowings of EUR Total intangible assets 13,883 14,187 1.3 (1.8) million Total tangible assets 1,166 783 Total non-curren